CHM 11.1% 1.0¢ chimeric therapeutics limited

it is really not considered price sensitive and therefore not...

  1. 624 Posts.
    lightbulb Created with Sketch. 4
    it is really not considered price sensitive and therefore not requiring an ASX announcement. I do however think that the management should be sending shareholders a monthly/quarterly note on what is happening - I guess however that it is now the litigation funder/lawyers that are calling the shots - CHM managemnt are probably only interested in the financial outcome (i.e. settlement).
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.